PHILADELPHIA — The latest science in why pain afflicts people differently, precision medicine and brain disorders, and how the bat genome informs the study of human aging, among many other topics, will be covered at the University of Pennsylvania’s Institute for Translational Medicine and Therapeutics’ (ITMAT) 12th Annual International Symposium. Speakers will include experts in epigenetics, neuroscience, informatics, and pain biology. ITMAT is based in the Perelman School of Medicine at the University of Pennsylvania.
Date: Monday and Tuesday, October 16 -17, 2017, starting at 8:00 am.
Location: Smilow Center for Translational Research, Rubenstein Auditorium and Lobby, 3400 Civic Center Blvd, Philadelphia, PA 19104. Enter through the Perelman Center for Advanced Medicine.
Garret A. FitzGerald, MD, FRS, director of ITMAT, will host the event. Speakers and talks include:
- Genetic editing in pain: towards pain precision medicine, Clifford Woolf, MB, BCh, PhD, Boston Children’s Hospital, Harvard Medical School,
- Do bats hold the secret of extended longevity?, Emma Teeling, PhD, University College Dublin, Ireland
- Molecular architecture of the circadian clock in mammals, Joseph S. Takahashi, PhD, Howard Hughes Medical Institute, UT Southwestern Medical Center
- Computational psychiatry, Ray Dolan, MD, FRS, University College London
- Translational genomics: linking genotype to phenotype at scale, Daniel J. Rader, MD, Perelman School of Medicine, University of Pennsylvania
- Endocannabinoid-based analgesics, Daniele Piomelli, PhD MD (h.c.), University of California, Irvine
For additional details and presentation times, visit the 2017 Agenda.
Registration is required for attendance and for participation via web:
If you plan to attend, please register and RSVP to Karen Kreeger at Karen.kreeger@uphs.upenn.edu.
Funding for this conference was made possible in part from the journal Science Translational Medicine.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.